Biogen Inc (BIIB)
165.54
-0.25
(-0.15%)
USD |
NASDAQ |
Nov 14, 11:57
Biogen Gross Profit (Annual): 7.302B for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 7.302B |
December 31, 2022 | 7.895B |
December 31, 2021 | 8.872B |
December 31, 2020 | 11.64B |
December 31, 2019 | 12.42B |
December 31, 2018 | 11.64B |
December 31, 2017 | 10.64B |
December 31, 2016 | 9.970B |
December 31, 2015 | 9.523B |
December 31, 2014 | 8.532B |
December 31, 2013 | 6.074B |
December 31, 2012 | 4.971B |
December 31, 2011 | 4.582B |
December 31, 2010 | 4.316B |
December 31, 2009 | 3.995B |
December 31, 2008 | 3.696B |
December 31, 2007 | 2.836B |
December 31, 2006 | 2.409B |
December 31, 2005 | 1.340B |
December 31, 2004 | 1.042B |
Date | Value |
---|---|
December 31, 2003 | -98.60M |
December 31, 2002 | 402.76M |
December 31, 2001 | 905.80M |
December 31, 2000 | 800.47M |
December 31, 1999 | 683.43M |
December 31, 1998 | 483.08M |
December 31, 1997 | 383.86M |
December 31, 1996 | 248.56M |
December 31, 1995 | 141.19M |
December 31, 1994 | 146.40M |
December 31, 1993 | 130.90M |
December 31, 1992 | 121.50M |
December 31, 1991 | 18.10M |
December 31, 1990 | 14.70M |
December 31, 1989 | 3.30M |
December 31, 1988 | -0.50M |
December 31, 1987 | -12.40M |
December 31, 1986 | -16.90M |
December 31, 1985 | 10.60M |
December 31, 1984 | -7.90M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
7.302B
Minimum
2023
12.42B
Maximum
2019
9.626B
Average
8.872B
Median
2021
Gross Profit (Annual) Benchmarks
Eli Lilly and Co | 27.04B |
Sage Therapeutics Inc | 84.30M |
Ionis Pharmaceuticals Inc | 778.51M |
Pfizer Inc | 33.54B |
Repligen Corp | 284.84M |